Anti-allodynic effect of Nefopam and Morphine in a rat model of Neuropathic Pain

Message:
Abstract:
Background
Neuropathic pain is a chronic pain due to a disorder in the peripheral or central nervous system with different pathophysiological mechanisms. Current treatments are not effective. Here we compared the analgesic effect of nefopam، and morphine in chronic constriction injury (CCI) model of neuropathic pain.
Methods
Male wistar rat (150-200g، n=8) were divided into 3 different groups: 1- Saline-treated CCI group، 2- Saline-treated sham group، and 3- Drug-treated CCI groups. In CCI model of neuropathic pain، the left sciatic nerve was exposed and 4 loose chromic gut ligatures were placed around the nerve proximal to the trifurcation. Ketamine 60mg/kg and xylazine 10 mg/kg were used for anesthesia. Nefopam (10، 20، 30mg/kg)، and morphine (1، 3، 5mg/kg) were injected 30 minutes before surgery and continued daily to day 14 post-ligation. Von Frey filaments for mechanical allodynia and acetone test for cold allodynia were respectively used as pain behavioral tests. Experiments were performed on day 0 (before surgery) and days 1، 3، 5،7،10 and 14 post injury. Behavioral studies were performed in a quiet room between 9:00 to 11:00 AM. All experiments followed the IASP guidelines on ethical standards for investigation of experimental pain in animals.
Results
Nefopam (20 and 30mg/kg) blocked mechanical and cold allodynia during the experimental period، but the analgesic effects of morphine (5mg/kg) lasted for 7 days.
Conclusions
It seems that nefopam could effectively reduce pain behavior compared to morphine with reduced adverse effects.
Language:
English
Published:
Novelty in Biomedicine, Volume:1 Issue: 1, Winter 2013
Pages:
16 to 22
magiran.com/p1199245  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!